World's Best Scientists 2026 revealed!
Paolo G. Casali

Paolo G. Casali

D-Index & Metrics

Medicine

D-Index
119
Citations
57460
World Ranking
3865
National Ranking
110

Overview

Paolo G. Casali is affiliated with the University of Milan in Italy and has established a notable presence within the field of medical research, particularly focused on oncology and related subfields. Their research output is firmly grounded within medicine, encompassing a total of 306 publications.

Their main subfields of study include:

  • Pulmonary and Respiratory Medicine
  • Oncology
  • Rheumatology
  • Pathology and Forensic Medicine
  • Cardiology and Cardiovascular Medicine

Casali's work predominantly addresses a range of main topics related to tumor research, diagnosis, and treatment. These include:

  • Sarcoma Diagnosis and Treatment
  • Vascular Tumors and Angiosarcomas
  • Cardiac tumors and thrombi
  • Bone Tumor Diagnosis and Treatments
  • Soft tissue tumor case studies
  • Gastrointestinal Tumor Research and Treatment
  • Uterine Myomas and Treatments

The researcher has published extensively in several prominent journals, with notable publication venues including:

  • Journal of Clinical Oncology
  • Annals of Oncology
  • ESMO Open
  • Cancer Treatment Reviews
  • Cancer

Recent selected papers authored or co-authored by Paolo G. Casali include:

  • Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up, 2021, Annals of Oncology
  • Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up, 2021, Annals of Oncology
  • The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients, 2020, European Journal of Cancer
  • Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up, 2021, Annals of Oncology
  • Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups, 2020, Journal of Clinical Oncology

Frequent collaborators in Paolo G. Casali's research include:

  • Alessandro Gronchi
  • Silvia Stacchiotti
  • Angelo Paolo Dei Tos
  • Giovanni Grignani
  • Anna Maria Frezza

Best Publications

  • Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

    George D Demetri;Allan T van Oosterom;Christopher R Garrett;Martin E Blackstein

  • Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

    Winette T A Van Der Graaf;Jean Yves Blay;Sant P. Chawla;Dong Wan Kim

  • Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial*

    Jaap Verweij;Paolo G. Casali;John Zalcberg;Axel LeCesne

  • Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial

    George D Demetri;Peter Reichardt;Yoon-Koo Kang;Jean-Yves Blay

  • Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up†

    P.G. Casali;N. Abecassis;S. Bauer;R. Biagini

  • NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines.

    George D. Demetri;Robert S. Benjamin;Charles D. Blanke;Jean Yves Blay

  • KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours

    Maria Debiec-Rychter;Raf Sciot;Axel Le Cesne;Marcus Schlemmer

  • Consensus meeting for the management of gastrointestinal stromal tumors Report of the GIST Consensus Conference of 20–21 March 2004, under the auspices of ESMO

    Jean Yves Blay;Sylvie Bonvalot;Paolo Casali;Haesun Choi

  • Role of Macrophage Targeting in the Antitumor Activity of Trabectedin

    Giovanni Germano;Roberta Frapolli;Cristina Belgiovine;Achille Anselmo

  • Rare cancers are not so rare: The rare cancer burden in Europe

    Gemma Gatta;Jan Maarten van der Zwan;Paolo G Casali;Sabine Siesling

  • Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

    A Santoro;T Tursz;H Mouridsen;Jaap Verweij

  • Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

    P.G. Casali;N. Abecassis;S. Bauer;R. Biagini

  • Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    P.G. Casali;J.-Y. Blay

  • Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project

    C.A. Stiller;A. Trama;D. Serraino;S. Rossi

  • Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS): A Report on 1007 Patients From the Multi-institutional Collaborative RPS Working Group

    Alessandro Gronchi;Dirk C. Strauss;Rosalba Miceli;Sylvie Bonvalot

  • Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Paolo G. Casali;Jean-Yves Blay;Alexia Bertuzzi;Stefan Bielack

  • Aggressive Surgical Policies in a Retrospectively Reviewed Single-Institution Case Series of Retroperitoneal Soft Tissue Sarcoma Patients

    Alessandro Gronchi;Salvatore Lo Vullo;Marco Fiore;Chiara Mussi

  • Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study

    Federica Grosso;Robin L. Jones;George D. Demetri;Ian R. Judson

  • Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    P.G. Casali;S. Bielack;N. Abecassis;H.T. Aro

  • Consensus meeting for the management of gastrointestinal stromal tumors Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO (vol 16, pg 566, 2005)

    JY Blay;S Bonvalot;P Casali;H Choi

Frequent Co-Authors

Alessandro Gronchi
Alessandro Gronchi University of Milan
Silvia Stacchiotti
Silvia Stacchiotti University of Milan
Silvana Pilotti
Silvana Pilotti University of Milan
Angelo Paolo Dei Tos
Angelo Paolo Dei Tos University of Padua
Jean-Yves Blay
Jean-Yves Blay Claude Bernard University Lyon 1
Marco Fiore
Marco Fiore IMDEA Networks
Peter Hohenberger
Peter Hohenberger Heidelberg University
Ian Judson
Ian Judson Institute of Cancer Research
Axel Le Cesne
Axel Le Cesne Institut Gustave Roussy
George D. Demetri
George D. Demetri Dana-Farber Cancer Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

There are several related online degrees and career pathways to consider if you are passionate about healthcare but want an alternative to studying traditional Medicine. Earning a degree in healthcare administration can open doors to leadership roles in hospitals, clinics, and other medical organizations. Many students look for the best online healthcare administration degree to gain management skills and fast-track their careers.

For nurses aiming to advance their qualifications, pursuing the asn to np pathway helps bridge the gap between an Associate Degree in Nursing and becoming a Nurse Practitioner. This pathway is efficient and often flexible for working professionals.

Another popular option is a nutrition degree online, which is ideal for those interested in health promotion, dietetics, or food science. As the demand grows for specialized expertise in nutrition and wellness, online learning offers both convenience and quality.

Finally, those aspiring to top executive roles can select from programs accredited by the Commission on Accreditation of Healthcare Management Education. Choosing from cahme-accredited Master of Healthcare Administration programs ensures a recognized and industry-endorsed qualification.

Best Scientists Citing Paolo G. Casali

Trending Scientists